Amazon gets EUA for direct-to-consumer, at-home COVID-19 tes

Amazon gets EUA for direct-to-consumer, at-home COVID-19 test


Dive Brief:
Amazon has received emergency use authorization from FDA for a direct-to-consumer kit for at-home, unsupervised self-collection of COVID-19 samples.
The tech giant first landed an EUA for its Amazon Real-Time RT-PCR Test for Detecting SARS-CoV-2 in March. In later filings, Amazon subsidiary STS Lab Holdco secured clearance for self-collection and a second EUA for a DTC product.
Amazon established laboratories in Kentucky and the U.K. to process COVID-19 tests for employees that could serve as a launchpad for entering the wider diagnostics market.
Dive Insight:
Amazon has been edging into healthcare for years, acquiring online pharmacy PillPack in 2018 before disclosing its on-demand healthcare service earlier this year. As COVID-19 spread, Amazon initiated an in-house COVID-19 testing service for employees, initially in the U.S. and later in the U.K. The site in the U.K. has now reportedly processed 900,000 samples.

Related Keywords

Kentucky , United States , , Lab Holdco , Dive Brief , Amazon Real Time , Policy Amp Regulation , Policy Regulation , Diagnostics , கெந்‌டகீ , ஒன்றுபட்டது மாநிலங்களில் , டைவ் சுருக்கமான , அமேசான் ரியல் நேரம் , பாலிஸீ ஆம்ப் ஒழுங்குமுறை , பாலிஸீ ஒழுங்குமுறை , பரிசோதனை ,

© 2025 Vimarsana